Position in DNLI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,189,971
+$1,271,324 QoQ
Shares Held
426,561
+1.8% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STEMPOINT CAPITAL LP holds $524,439,182 across 65 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TNGX |
Tango Therapeutics, Inc.
|
1,223,019 | $38,231,573 | |
| 2 | ABVX |
Abivax S.A.
|
283,657 | $37,800,131 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
159,943 | $29,954,125 | |
| 4 | ERAS |
Erasca, Inc.
|
1,565,913 | $28,687,526 | |
| 5 | TYRA |
Tyra Biosciences, Inc.
|
632,754 | $20,210,162 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
200,851 | $19,578,955 | |
| 7 | ELVN |
Enliven Therapeutics, Inc.
|
346,914 | $17,605,885 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
602,686 | $16,260,468 |
All Filings in DNLI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,189,971 | 426,561 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,918,647 | 419,058 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,187,248 | 1,734,659 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,903,730 | 707,915 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,068,925 | 667,078 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,908,604 | 584,328 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,216,116 | 282,050 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,828,452 | 251,010 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||